speb/financial-data huggingface dataset:
CYRX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1141000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1141000.00
CYRX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CYRX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CYRX balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
CYRX balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
CYRX income_statement (annual, 2025-12-31) — Basic Average Shares: 50071665.00
CYRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 49759264.00
CYRX income_statement (annual, 2025-12-31) — Basic EPS: 1.40
CYRX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.27
CYRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 45289000.00
CYRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 255811000.00
CYRX balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 20282000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 20282000.00
CYRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -19505000.00
CYRX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4944000.00
CYRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 44374000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 44374000.00
CYRX balance_sheet (annual, 2025-12-31) — Capital Stock: 42325000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 42325000.00
CYRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 250494000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 250494000.00
CYRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 411208000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 411208000.00
CYRX balance_sheet (annual, 2025-12-31) — Cash Equivalents: 208124000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 208124000.00
CYRX balance_sheet (annual, 2025-12-31) — Cash Financial: 42370000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 42370000.00
CYRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -21074000.00
CYRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2153000.00
CYRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 250323000.00
CYRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 56000.00
CYRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8580000.00
CYRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 919000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -3464000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -741000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1909000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 2118000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Inventory: -2185000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -97000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -5036000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1069000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 445000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -621000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Payable: -3464000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Payable: -741000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1555000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1377000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1164000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -3172000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Receivables: -6527000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1301000.00
CYRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -13694000.00
CYRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2281000.00
CYRX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -6527000.00
CYRX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 1301000.00
CYRX cash_flow (annual, 2025-12-31) — Changes In Cash: 220669000.00
CYRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1178000.00
CYRX balance_sheet (annual, 2025-12-31) — Common Stock: 50000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 50000.00
CYRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 460363000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 460363000.00
CYRX cash_flow (annual, 2025-12-31) — Common Stock Payments: -10011000.00
CYRX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -2007000.00
CYRX balance_sheet (annual, 2025-12-31) — Construction In Progress: 18089000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 18089000.00
CYRX income_statement (annual, 2025-12-31) — Cost Of Revenue: 93123000.00
CYRX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 23739000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 9625000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 9625000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Assets: 476174000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 476174000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4555000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4555000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Debt: 185257000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Debt: 185257000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 189812000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 189812000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 943000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 943000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 943000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 943000.00
CYRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 219018000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 219018000.00
CYRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 27712000.00
CYRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 6355000.00
CYRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 27712000.00
CYRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6355000.00
CYRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 50071665.00
CYRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 49759264.00
CYRX income_statement (annual, 2025-12-31) — Diluted EPS: 1.40
CYRX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.27
CYRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 70301000.00
CYRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -13644000.00
CYRX income_statement (annual, 2025-12-31) — EBIT: -29809000.00
CYRX income_statement (quarterly, 2025-12-31) — EBIT: -6761000.00
CYRX income_statement (annual, 2025-12-31) — EBITDA: -2097000.00
CYRX income_statement (quarterly, 2025-12-31) — EBITDA: -406000.00
CYRX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -15464000.00
CYRX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -4139000.00
CYRX cash_flow (annual, 2025-12-31) — End Cash Position: 250494000.00
CYRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 250494000.00
CYRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -21074000.00
CYRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2153000.00
CYRX cash_flow (annual, 2025-12-31) — Free Cash Flow: -28085000.00
CYRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4025000.00
CYRX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 2209000.00
CYRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -74000.00
CYRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -116953000.00
CYRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 3094000.00
CYRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 1012000.00
CYRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 863000.00
CYRX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 9798000.00
CYRX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 3357000.00
CYRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3483000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3483000.00
CYRX balance_sheet (annual, 2025-12-31) — Goodwill: 22400000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Goodwill: 22400000.00
CYRX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 160482000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 160482000.00
CYRX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 34500000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 34500000.00
CYRX balance_sheet (annual, 2025-12-31) — Gross PPE: 174651000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 174651000.00
CYRX income_statement (annual, 2025-12-31) — Gross Profit: 83054000.00
CYRX income_statement (quarterly, 2025-12-31) — Gross Profit: 21711000.00
CYRX income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CYRX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 2191000.00
CYRX cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1257000.00
CYRX income_statement (annual, 2025-12-31) — Interest Expense: 2361000.00
CYRX income_statement (quarterly, 2025-12-31) — Interest Expense: 634000.00
CYRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2361000.00
CYRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 634000.00
CYRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1628000.00
CYRX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 703000.00
CYRX balance_sheet (annual, 2025-12-31) — Inventory: 23188000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Inventory: 23188000.00
CYRX balance_sheet (annual, 2025-12-31) — Invested Capital: 646707000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 646707000.00
CYRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 250323000.00
CYRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 56000.00
CYRX balance_sheet (annual, 2025-12-31) — Land And Improvements: 824000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 824000.00
CYRX balance_sheet (annual, 2025-12-31) — Leases: 43153000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Leases: 43153000.00
CYRX balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
CYRX balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
CYRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 39819000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 39819000.00
CYRX balance_sheet (annual, 2025-12-31) — Long Term Debt: 1087000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1087000.00
CYRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 40906000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 40906000.00
CYRX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -15035000.00
CYRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -145000.00
CYRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 29337000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 29337000.00
CYRX cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 210239000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CYRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -10011000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2007000.00
CYRX income_statement (annual, 2025-12-31) — Net Income: 78301000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income: -11644000.00
CYRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 70301000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -13644000.00
CYRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -33969000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8521000.00
CYRX income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 112270000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: -3123000.00
CYRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 78301000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11644000.00
CYRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -33969000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8521000.00
CYRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 78301000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -11644000.00
CYRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 78301000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -11644000.00
CYRX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -3066000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 523000.00
CYRX income_statement (annual, 2025-12-31) — Net Interest Income: -2361000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Interest Income: -634000.00
CYRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 59589000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 5000000.00
CYRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -15035000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -145000.00
CYRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -15035000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -145000.00
CYRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2361000.00
CYRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -634000.00
CYRX balance_sheet (annual, 2025-12-31) — Net PPE: 125168000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 125168000.00
CYRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -16439000.00
CYRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -5467000.00
CYRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 342156000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 342156000.00
CYRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1073000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1073000.00
CYRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1354000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1354000.00
CYRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1073000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1073000.00
CYRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1354000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1354000.00
CYRX balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 2092000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 2092000.00
CYRX income_statement (annual, 2025-12-31) — Normalized EBITDA: -11895000.00
CYRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3763000.00
CYRX income_statement (annual, 2025-12-31) — Normalized Income: -41709420.00
CYRX income_statement (quarterly, 2025-12-31) — Normalized Income: -11173030.00
CYRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -8580000.00
CYRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 919000.00
CYRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -113732000.00
CYRX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 3883000.00
CYRX income_statement (annual, 2025-12-31) — Operating Income: -36806000.00
CYRX income_statement (quarterly, 2025-12-31) — Operating Income: -10031000.00
CYRX income_statement (annual, 2025-12-31) — Operating Revenue: 176177000.00
CYRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 45450000.00
CYRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 49850793.00
CYRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49850793.00
CYRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 8419000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 8419000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 185257000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 185257000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -3483000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -3483000.00
CYRX income_statement (annual, 2025-12-31) — Other Income Expense: 6997000.00
CYRX income_statement (quarterly, 2025-12-31) — Other Income Expense: 3270000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 138082000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 138082000.00
CYRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3307000.00
CYRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2018000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1073000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1073000.00
CYRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -2801000.00
CYRX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -87000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Properties: 60656000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 60656000.00
CYRX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 160714000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 160714000.00
CYRX balance_sheet (annual, 2025-12-31) — Payables: 15283000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Payables: 15283000.00
CYRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 24908000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 24908000.00
CYRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3355000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3355000.00
CYRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 42275000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 42275000.00
CYRX income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 8000000.00
CYRX income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2000000.00
CYRX balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 42275000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 42275000.00
CYRX income_statement (annual, 2025-12-31) — Pretax Income: -32170000.00
CYRX income_statement (quarterly, 2025-12-31) — Pretax Income: -7395000.00
CYRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3972000.00
CYRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -1000.00
CYRX cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CYRX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CYRX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -3066000.00
CYRX cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 523000.00
CYRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CYRX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CYRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -16439000.00
CYRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5467000.00
CYRX balance_sheet (annual, 2025-12-31) — Receivables: 33359000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Receivables: 33359000.00
CYRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 93123000.00
CYRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 23739000.00
CYRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 27712000.00
CYRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6355000.00
CYRX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -15035000.00
CYRX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -145000.00
CYRX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -10011000.00
CYRX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2007000.00
CYRX income_statement (annual, 2025-12-31) — Research And Development: 17041000.00
CYRX income_statement (quarterly, 2025-12-31) — Research And Development: 4466000.00
CYRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -688884000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -688884000.00
CYRX cash_flow (annual, 2025-12-31) — Sale Of Business: 210239000.00
CYRX cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CYRX cash_flow (annual, 2025-12-31) — Sale Of Investment: 59589000.00
CYRX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5000000.00
CYRX income_statement (annual, 2025-12-31) — Selling General And Administration: 102819000.00
CYRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 27276000.00
CYRX balance_sheet (annual, 2025-12-31) — Share Issued: 49850793.00
CYRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 49850793.00
CYRX income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CYRX income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CYRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 11032000.00
CYRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2431000.00
CYRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 502638000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 502638000.00
CYRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 299881000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 299881000.00
CYRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2057580.00
CYRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 704970.00
CYRX income_statement (annual, 2025-12-31) — Tax Provision: 1799000.00
CYRX income_statement (quarterly, 2025-12-31) — Tax Provision: 1126000.00
CYRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CYRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (annual, 2025-12-31) — Total Assets: 764989000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 764989000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 503725000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 503725000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Debt: 230718000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 230718000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 502638000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 502638000.00
CYRX income_statement (annual, 2025-12-31) — Total Expenses: 212983000.00
CYRX income_statement (quarterly, 2025-12-31) — Total Expenses: 55481000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 262351000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 262351000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 288815000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 288815000.00
CYRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 43333000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 43333000.00
CYRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -36806000.00
CYRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -10031000.00
CYRX income_statement (annual, 2025-12-31) — Total Unusual Items: 9798000.00
CYRX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 3357000.00
CYRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 9798000.00
CYRX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3357000.00
CYRX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -1506000.00
CYRX cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 157000.00
CYRX balance_sheet (annual, 2025-12-31) — Working Capital: 257156000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 257156000.00
CYRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 31527000.00
CYRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 47798000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15937000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 39004000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1153304000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1159000.00
CYRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 49897817.00
CYRX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.25
CYRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 250494000.00
CYRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -10282000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 43913000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 44325000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 272912000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 403634000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 230714000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 42198000.00
CYRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 85000.00
CYRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 18718000.00
CYRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3735000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -596000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 4061000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: 1319000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1212000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1615000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -596000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3465000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2239000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -5733000.00
CYRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 1693000.00
CYRX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -5733000.00
CYRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 22538000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 50000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 450714000.00
CYRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 25885000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 470535000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4060000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Debt: 185549000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 189609000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2314000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2314000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 224867000.00
CYRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6402000.00
CYRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6402000.00
CYRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 49897817.00
CYRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.25
CYRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -12544000.00
CYRX income_statement (quarterly, 2026-03-31) — EBIT: -8892000.00
CYRX income_statement (quarterly, 2026-03-31) — EBITDA: -2490000.00
CYRX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -120000.00
CYRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 272912000.00
CYRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 85000.00
CYRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -6547000.00
CYRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 1044000.00
CYRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 30000.00
CYRX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3090000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -3212000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Goodwill: 22137000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 160858000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 40163000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 129104000.00
CYRX income_statement (quarterly, 2026-03-31) — Gross Profit: 21913000.00
CYRX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 502000.00
CYRX income_statement (quarterly, 2026-03-31) — Interest Expense: 432000.00
CYRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 432000.00
CYRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 28000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Inventory: 21750000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 637290000.00
CYRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 18718000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 39853000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1027000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 40880000.00
CYRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -144000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income: -10544000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -12544000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -9432000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -1112000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10544000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -9432000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -10544000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10544000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -301000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Interest Income: -432000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 29000000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -144000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -144000.00
CYRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -432000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 129104000.00
CYRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -9981000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 334131000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1066000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1580000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1066000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1580000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 2046000.00
CYRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -5580000.00
CYRX income_statement (quarterly, 2026-03-31) — Normalized Income: -11286000.00
CYRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3735000.00
CYRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1074000.00
CYRX income_statement (quarterly, 2026-03-31) — Operating Income: -9614000.00
CYRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 47798000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 50197906.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6147000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 185549000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3212000.00
CYRX income_statement (quarterly, 2026-03-31) — Other Income Expense: 722000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 138721000.00
CYRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1653000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1293000.00
CYRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -2368000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 129104000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 130722000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Payables: 15937000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 15937000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 17007000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 44275000.00
CYRX income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 2000000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 44275000.00
CYRX income_statement (quarterly, 2026-03-31) — Pretax Income: -9324000.00
CYRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 229000.00
CYRX cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -301000.00
CYRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -9981000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Receivables: 39004000.00
CYRX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 25885000.00
CYRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6402000.00
CYRX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -144000.00
CYRX income_statement (quarterly, 2026-03-31) — Research And Development: 3907000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -699428000.00
CYRX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 29000000.00
CYRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 27620000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 50197906.00
CYRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2395000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 494989000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 289856000.00
CYRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1236000.00
CYRX income_statement (quarterly, 2026-03-31) — Tax Provision: 108000.00
CYRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CYRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 763609000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 496016000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 230489000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 494989000.00
CYRX income_statement (quarterly, 2026-03-31) — Total Expenses: 57412000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 268620000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 293074000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 43753000.00
CYRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -9614000.00
CYRX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 3090000.00
CYRX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 3090000.00
CYRX cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 1062000.00
CYRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 245668000.00
CYTK cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 2844000.00
CYTK balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 87000000.00
CYTK balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 87000000.00
CYTK balance_sheet (annual, 2021-12-31) — Prepaid Assets: 12215000.00
CYTK income_statement (annual, 2022-12-31) — +Operating Expense: 418790000.00
CYTK income_statement (annual, 2022-12-31) — +Total Revenue: 94588000.00
CYTK balance_sheet (annual, 2022-12-31) — Accounts Payable: 25611000.00
CYTK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 147000.00
CYTK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -17094000.00
CYTK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1481590000.00
CYTK cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CYTK balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 46708000.00
CYTK income_statement (annual, 2022-12-31) — Basic Average Shares: 89825000.00
CYTK income_statement (annual, 2022-12-31) — Basic EPS: -4.33
CYTK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 112666000.00
CYTK cash_flow (annual, 2022-12-31) — Capital Expenditure: -11335000.00
CYTK balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 139724000.00
CYTK balance_sheet (annual, 2022-12-31) — Capital Stock: 94000.00
CYTK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 65582000.00
CYTK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 782577000.00
CYTK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 516166000.00
CYTK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -262134000.00
CYTK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -299516000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Account Payable: 4524000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 10844000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -2330000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -87000000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Payable: 4524000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 15368000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -7414000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Receivables: 56672000.00
CYTK cash_flow (annual, 2022-12-31) — Change In Working Capital: -24704000.00
CYTK cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 56672000.00
CYTK cash_flow (annual, 2022-12-31) — Changes In Cash: -45484000.00
CYTK balance_sheet (annual, 2022-12-31) — Common Stock: 94000.00
CYTK balance_sheet (annual, 2022-12-31) — Common Stock Equity: -107900000.00
CYTK cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CYTK balance_sheet (annual, 2022-12-31) — Construction In Progress: 741000.00
CYTK income_statement (annual, 2022-12-31) — Cost Of Revenue: 240813000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 22329000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Assets: 795186000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 12829000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Debt: 958000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 13787000.00
CYTK balance_sheet (annual, 2022-12-31) — Current Liabilities: 84617000.00
CYTK cash_flow (annual, 2022-12-31) — Depreciation: 5814000.00
CYTK cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5814000.00
CYTK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5814000.00
CYTK income_statement (annual, 2022-12-31) — Diluted Average Shares: 89825000.00
CYTK income_statement (annual, 2022-12-31) — Diluted EPS: -4.33
CYTK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -388955000.00
CYTK income_statement (annual, 2022-12-31) — EBIT: -337799000.00
CYTK income_statement (annual, 2022-12-31) — EBITDA: -331985000.00
CYTK cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
CYTK cash_flow (annual, 2022-12-31) — End Cash Position: 67182000.00
CYTK cash_flow (annual, 2022-12-31) — Financing Cash Flow: 516166000.00
CYTK cash_flow (annual, 2022-12-31) — Free Cash Flow: -310851000.00
CYTK cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 107000.00
CYTK cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
CYTK balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -3590000.00
CYTK income_statement (annual, 2022-12-31) — General And Administrative Expense: 177977000.00
CYTK balance_sheet (annual, 2022-12-31) — Gross PPE: 180284000.00
CYTK income_statement (annual, 2022-12-31) — Gross Profit: -146225000.00
CYTK income_statement (annual, 2022-12-31) — Interest Expense: 51156000.00
CYTK income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 51156000.00
CYTK income_statement (annual, 2022-12-31) — Interest Income: 11342000.00
CYTK income_statement (annual, 2022-12-31) — Interest Income Non Operating: 11342000.00
CYTK cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 15165000.00
CYTK balance_sheet (annual, 2022-12-31) — Invested Capital: 502676000.00
CYTK cash_flow (annual, 2022-12-31) — Investing Cash Flow: -262134000.00
CYTK balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 46708000.00
CYTK balance_sheet (annual, 2022-12-31) — Investments And Advances: 46708000.00
CYTK cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CYTK cash_flow (annual, 2022-12-31) — Issuance Of Debt: 523586000.00
CYTK balance_sheet (annual, 2022-12-31) — Leases: 65912000.00
CYTK balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 126895000.00
CYTK balance_sheet (annual, 2022-12-31) — Long Term Debt: 609618000.00
CYTK balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 736513000.00
CYTK cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 523586000.00
CYTK cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -188925000.00
CYTK balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 9956000.00
CYTK cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CYTK balance_sheet (annual, 2022-12-31) — Net Debt: 544994000.00
CYTK income_statement (annual, 2022-12-31) — Net Income: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -388955000.00
CYTK cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -388955000.00
CYTK income_statement (annual, 2022-12-31) — Net Interest Income: -39814000.00
CYTK cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -250799000.00
CYTK cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 334661000.00
CYTK cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 334661000.00
CYTK income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -39814000.00
CYTK cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 163962000.00
CYTK balance_sheet (annual, 2022-12-31) — Net PPE: 163190000.00
CYTK cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -11335000.00
CYTK balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -107900000.00
CYTK balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
CYTK balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 0.00
CYTK income_statement (annual, 2022-12-31) — Normalized EBITDA: -307046000.00
CYTK income_statement (annual, 2022-12-31) — Normalized Income: -364016000.00
CYTK cash_flow (annual, 2022-12-31) — Operating Cash Flow: -299516000.00
CYTK cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2800000.00
CYTK income_statement (annual, 2022-12-31) — Operating Income: -324202000.00
CYTK income_statement (annual, 2022-12-31) — Operating Revenue: 94588000.00
CYTK balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 94833975.00
CYTK balance_sheet (annual, 2022-12-31) — Other Current Assets: 12462000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 958000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1123000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -3590000.00
CYTK income_statement (annual, 2022-12-31) — Other Gand A: 177977000.00
CYTK income_statement (annual, 2022-12-31) — Other Income Expense: -24939000.00
CYTK cash_flow (annual, 2022-12-31) — Other Non Cash Items: 57676000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 9691000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 301545000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Properties: 103675000.00
CYTK balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 716995000.00
CYTK income_statement (annual, 2022-12-31) — Other Special Charges: 24939000.00
CYTK balance_sheet (annual, 2022-12-31) — Payables: 25611000.00
CYTK balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 47940000.00
CYTK balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 21767000.00
CYTK balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CYTK income_statement (annual, 2022-12-31) — Pretax Income: -388955000.00
CYTK cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 17543000.00
CYTK balance_sheet (annual, 2022-12-31) — Properties: 0.00
CYTK cash_flow (annual, 2022-12-31) — Purchase Of Investment: -855393000.00
CYTK cash_flow (annual, 2022-12-31) — Purchase Of PPE: -11335000.00
CYTK balance_sheet (annual, 2022-12-31) — Receivables: 147000.00